Literature DB >> 22401302

Statistical analysis of survival data from radiation countermeasure experiments.

Reid D Landes1, Shelly Y Lensing, Ralph L Kodell, Martin Hauer-Jensen.   

Abstract

We present an introduction to, and examples of, Cox proportional hazards regression in the context of animal lethality studies of potential radioprotective agents. This established method is seldom used to analyze survival data collected in such studies, but is appropriate in many instances. Presenting a hypothetical radiation study that examines the efficacy of a potential radioprotectant both in the absence and presence of a potential modifier, we detail how to implement and interpret results from a Cox proportional hazards regression analysis used to analyze the survival data, and we provide relevant SAS® code. Cox proportional hazards regression analysis of survival data from lethal radiation experiments (1) considers the whole distribution of survival times rather than simply the commonly used proportions of animals that survived, (2) provides a unified analysis when multiple factors are present, and (3) can increase statistical power by combining information across different levels of a factor. Cox proportional hazards regression should be considered as a potential statistical method in the toolbox of radiation researchers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22401302      PMCID: PMC3387733          DOI: 10.1667/rr2872.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  18 in total

1.  The role of the biostatistician in cancer research.

Authors:  E A Gehan
Journal:  Biomed Pharmacother       Date:  2001-11       Impact factor: 6.529

Review 2.  Major radiation exposure--what to expect and how to respond.

Authors:  Fred A Mettler; George L Voelz
Journal:  N Engl J Med       Date:  2002-05-16       Impact factor: 91.245

3.  Influence of the leaf extract of Mentha arvensis Linn. (mint) on the survival of mice exposed to different doses of gamma radiation.

Authors:  Ganesh Chandra Jagetia; Manjeshwar Shrinath Baliga
Journal:  Strahlenther Onkol       Date:  2002-02       Impact factor: 3.621

4.  Efficiency of the logistic regression and Cox proportional hazards models in longitudinal studies.

Authors:  I Annesi; T Moreau; J Lellouch
Journal:  Stat Med       Date:  1989-12       Impact factor: 2.373

5.  New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2002-05-31

6.  Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group.

Authors:  Jamie K Waselenko; Thomas J MacVittie; William F Blakely; Nicki Pesik; Albert L Wiley; William E Dickerson; Horace Tsu; Dennis L Confer; C Norman Coleman; Thomas Seed; Patrick Lowry; James O Armitage; Nicholas Dainiak
Journal:  Ann Intern Med       Date:  2004-06-15       Impact factor: 25.391

7.  Determination of sample sizes for demonstrating efficacy of radiation countermeasures.

Authors:  Ralph L Kodell; Shelly Y Lensing; Reid D Landes; K Sree Kumar; Martin Hauer-Jensen
Journal:  Biometrics       Date:  2009-05-07       Impact factor: 2.571

8.  gamma-Tocotrienol ameliorates intestinal radiation injury and reduces vascular oxidative stress after total-body irradiation by an HMG-CoA reductase-dependent mechanism.

Authors:  Maaike Berbée; Qiang Fu; Marjan Boerma; Junru Wang; K Sree Kumar; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2009-05       Impact factor: 2.841

9.  The somatostatin analog SOM230 (pasireotide) ameliorates injury of the intestinal mucosa and increases survival after total-body irradiation by inhibiting exocrine pancreatic secretion.

Authors:  Qiang Fu; Maaike Berbée; Marjan Boerma; Junru Wang; Herbert A Schmid; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2009-06       Impact factor: 2.841

10.  Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector.

Authors:  Sanchita P Ghosh; Shilpa Kulkarni; Kevin Hieber; Raymond Toles; Lyudmila Romanyukha; Tzu-Cheg Kao; Martin Hauer-Jensen; K Sree Kumar
Journal:  Int J Radiat Biol       Date:  2009-07       Impact factor: 2.694

View more
  2 in total

1.  Practical advice on calculating confidence intervals for radioprotection effects and reducing animal numbers in radiation countermeasure experiments.

Authors:  Reid D Landes; Shelly Y Lensing; Ralph L Kodell; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2013-10-28       Impact factor: 2.841

2.  Study logistics that can impact medical countermeasure efficacy testing in mouse models of radiation injury.

Authors:  Andrea L DiCarlo; Zulmarie Perez Horta; Carmen I Rios; Merriline M Satyamitra; Lanyn P Taliaferro; David R Cassatt
Journal:  Int J Radiat Biol       Date:  2020-09-24       Impact factor: 2.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.